Kidney Transplant Medication - enteric-coated myfortic mycophenolic acid delayed-release tablet














 

Featured Click - Quiz: How are you feeling?
  Novartis Pharma US

 
About myfortic and CellCept


The Immunosuppressive
Benefits You Need


myfortic and CellCept, taken with cyclosporine and corticosteroids, are medications given to people who have received kidney transplants to help keep their new organ healthy. Both myfortic and CellCept deliver the same, highly effective immunosuppressive drug. Its scientific name is mycophenolic acid but it's easier to remember (and pronounce) as MPA. Antirejection medications like myfortic and CellCept are called immunosuppressants because they help hold in check the full response of the body's immune system.

What side effects could occur taking myfortic or CellCept?
Some people taking myfortic or CellCept experience stomach and intestinal side effects that could affect quality of life. These patients should talk to their doctor or transplant team about their options.

The most common gastrointestinal side effects with both drugs are diarrhea and vomiting. Other side effects include leukopenia (a decrease in your white blood cells), sepsis (an infection in the blood), and a higher incidence of certain other infections.

Patients taking antirejection medications have a slightly higher chance of experiencing nausea, urinary tract infection, and dyspepsia (recurrent discomfort or pain that may occur in or around the stomach area).

People who take antirejection medication have a greater chance of developing lymphomas and other cancers, especially skin cancer. Wear protective clothing when you are in the sun and use a sunscreen with a high protection factor (SPF 30 and above), especially if your skin is very fair or you have a family history of skin cancer.

Find out how myfortic delivers the same medication as CellCept but with a protective coating.
The myfortic Difference >>

Click here for complete prescribing information, which includes contraindications, warnings, precautions, and adverse events.

Back to top 




CellCept® is a registered trademark of Roche Laboratories, Inc.

myfortic Home | Before a Kidney Transplant | After a Kidney Transplant
Treatment Options: myfortic and CellCept | Life With myfortic | More Transplant Resources

Prescribing Information | Important Safety Information | For Healthcare Professionals

Glossary | Site Guide | Site Map | Contact Us

Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement.
Copyright ©2008
Novartis Pharmaceuticals Corporation. All rights reserved.